B7-H3-targeted (212)Pb radioimmunotherapy of ovarian cancer in preclinical models

INTRODUCTION: Novel therapies that effectively kill both differentiated cancer cells and cancer initiating cells (CICs), which are implicated in causing chemotherapy-resistance and disease recurrence, are needed to reduce the morbidity and mortality of ovarian cancer. These studies used monoclonal a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nucl Med Biol
Autors principals: Kasten, Benjamin B., Arend, Rebecca C., Katre, Ashwini A., Kim, Harrison, Fan, Jinda, Ferrone, Soldano, Zinn, Kurt R., Buchsbaum, Donald J.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5340614/
https://ncbi.nlm.nih.gov/pubmed/28104527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nucmedbio.2017.01.003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars